Back to Search

Gimeracil,Oteracil Potassium,Tegafur – Uses, Dosage, and Brands in UAE

Brand Name: TS-1
Strength: 7.25 mg,24.5 mg,25 mg | Form: Capsules
Price in UAE: AED 8372.00
Available in UAE pharmacies

About Gimeracil,Oteracil Potassium,Tegafur

Class: | Antineoplastic agent (combination chemotherapy) Use: | Treatment of gastric cancer and colorectal cancer, particularly in patients who are not candidates for surgery or have metastatic disease. Adult dose: | Typically, the recommended dose is 80 mg/m²/day of Tegafur, administered orally in combination with Gimeracil and Oteracil Potassium, for 28 days followed by a 14-day rest period. Pediatric dose: | Safety and efficacy in pediatric patients have not been established; use is not

Drug Class

Antineoplastic agent (combination chemotherapy)

Uses & Indications

Treatment of gastric cancer and colorectal cancer, particularly in patients who are not candidates for surgery or have metastatic disease.

Storage Requirements

Store at room temperature (15°C to 30°C or 59°F to 86°F) in a tightly closed container, protected from moisture and light.

Manufacturer & Packaging

Manufacturer: Taiho Pharmaceutical Co. Ltd, JAPAN

Package Size

56's (14's Blister x 4)

Price & Supplier

Price in UAE: AED 8372.00

Dosage Information

Adult Dose

Typically, the recommended dose is 80 mg/m²/day of Tegafur, administered orally in combination with Gimeracil and Oteracil Potassium, for 28 days followed by a 14-day rest period.

Pediatric Dose

Safety and efficacy in pediatric patients have not been established; use is not recommended.

Side Effects

Common side effects include nausea, vomiting, diarrhea, fatigue, loss of appetite, and myelosuppression (e.g., leukopenia, anemia, thrombocytopenia).

Contraindications & Precautions

Hypersensitivity to any component of the formulation, severe bone marrow suppression, and pregnancy (due to potential teratogenic effects).

Important Warnings

Monitor for signs of myelosuppression, gastrointestinal toxicity, and potential drug interactions. Use with caution in patients with liver or kidney impairment. Pregnant or breastfeeding women should avoid use due to potential risks to the fetus or infant.

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

View All Antineoplastic agent (combination chemotherapy) Medicines Browse All Categories